Medical Image Analysis Software Market
完整報告名稱與涵蓋範圍
Medical Image Analysis Software Market by Function (Reconstruction, Detection, Analysis, Reporting), Tech (AI [ML, Computer Vision), Image (3D, 4D), Modality (CT, PET/SPECT, Mammo), Indication (Onco, Cardio), End User (Hospital) - Global Forecast to 2031
報告摘要
The global medical image analysis software market is projected to reach USD 6.42 billion by 2031 from USD 4.35 billion in 2026, at a CAGR of 8.1%. Market growth is mainly driven by the rising need to reduce radiologist workload across detection, segmentation, reconstruction, and reporting workflows. Hospitals are using AI-based software to triage urgent findings, reduce interpretation time, and manage rising CT, MRI, ultrasound, and mammography volumes. Diagnostic imaging centers are adopting cloud-based platforms to improve report turnaround and support remote reading across multiple sites. Academic and research institutions are increasingly relying on AI software for multi-center clinical studies and disease-specific research as imaging datasets grow larger and more complex. The market is further supported by integrated AI-enabled hardware, deep learning algorithms, cloud-native platforms, and enterprise imaging acquisitions that help reduce cost and improve diagnostic turnaround time.
“Deep learning accounted for the largest share of the AI-enabled technology market in 2025.”
By AI-enabled technology, the medical image analysis software market is segmented into machine learning, deep learning, computer vision, and natural language processing. The deep learning segment accounted for the largest market share in 2025, as radiology AI vendors continue to build convolutional neural network-based models for detecting fractures, tumors, strokes, and other abnormalities directly from raw pixel data. This segment includes automated lesion detection, image segmentation, quantitative measurement, and abnormality classification. Adoption is especially strong because deep learning models can be trained on large, multi-institutional imaging datasets and validated for FDA clearance faster than older rule-based approaches.
“Diagnostic imaging centers are expected to register the fastest growth among end users during the forecast period.”
Based on end user, the medical image analysis software market is segmented into hospitals, diagnostic imaging centers, academic and research institutions, and other end users. Among these, diagnostic imaging centers are expected to record the fastest growth during the forecast period. The growth is mainly driven by rising outpatient imaging volumes, the need for faster report turnaround, and increasing use of AI to support remote and teleradiology reading models. Diagnostic imaging centers are increasingly using AI-based triage and reporting software because they process high volumes of standardized scans with limited on-site radiologist staff. As outpatient imaging demand rises and centers compete on turnaround time, AI-based detection and workflow software is becoming a priority investment area to protect margins and improve patient throughput.
“Asia Pacific to witness the highest growth rate in the medical image analysis software market during the forecast period.”
Asia Pacific is expected to witness the highest growth rate in the medical image analysis software market during the forecast period. The growth is mainly supported by rising healthcare digitization, expanding private hospital networks, growing insurance coverage, and a severe shortage of radiologists relative to imaging demand. Countries such as India, China, Japan, South Korea, Australia, and the Philippines are becoming important markets as healthcare organizations try to manage higher patient volumes, reduce diagnostic delays, and improve access to specialist imaging review in rural and tier-2/tier-3 areas. India faces a critical radiologist shortage, with estimates suggesting fewer than one radiologist per 100,000 people in rural areas. India's Ayushman Bharat Digital Mission is also building the digital infrastructure needed for connected health records, having created 799 million digital health IDs and linked 410,000 healthcare facilities as of August 2025, which can increase demand for cloud-based, AI-enabled imaging software over time. Asia Pacific is also a strong delivery hub for medical imaging AI because of its large skilled technical workforce, cost-efficient software development, and growing base of homegrown AI radiology vendors. Qure.ai, an Indian AI radiology company, was recognized in 2025 by Time Magazine as one of the world's most influential AI healthcare companies, deploying its solutions in over 100 countries with multiple FDA clearances.
The breakdown of primary participants is as given below:
• By Company Type - Tier 1: 60%, Tier 2: 30%, and Tier 3: 10%
• By Designation - C-level: 30%, Director-level: 50%, and Others: 20%
• By Region - North America: 45%, Europe: 20%, Asia Pacific: 25%, Rest of the world: 10%.
Siemens Healthineers AG (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), FUJIFILM Holdings Corporation (Japan), and Aidoc Medical Ltd. (Israel) are key players in the medical image analysis software market.
The study includes an in-depth competitive analysis of these key players in the medical image analysis software market, with their company profiles, recent developments, and key market strategies.
Research Coverage
This research report categorizes the medical image analysis software market by Type [Integrated Software, Standalone Software], Technology [AI-Enabled Technology {Machine Learning, Deep Learning, Computer Vision, Natural Language Processing}, Conventional Technology], Function [Reconstruction & Visualization, Detection & Localization, Segmentation & Analysis, Registration & Comparison, Reporting & Communication, Clinical Decision Support], Image Type [2D Imaging, 3D Imaging, 4D Imaging], Modality [Radiography (X-Ray), Computed Tomography (CT) {High-end Slice CT, Mid-end Slice CT, Low-end Slice CT}, Magnetic Resonance Imaging (MRI) {Closed MRI Systems, Open MRI Systems}, Ultrasound Imaging {2D Ultrasound Systems, 3D and 4D Ultrasound Systems, Doppler Imaging}, Nuclear Imaging {Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)}, Mammography, Combined/Hybrid Modalities {PET/CT, SPECT/CT, PET/MR}, Others], Therapeutic Area [Cardiology, Oncology, Neurology, Orthopedics, Dental, Obstetrics & Gynecology, Mammography/Breast Imaging, Others], End User [Hospitals, Diagnostic Imaging Centers, Academic & Research Institutions, Other End Users], and Region [North America, Europe, Asia Pacific, Latin America, and Middle East & Africa]. The report covers detailed information on major factors such as drivers, restraints, challenges, and opportunities influencing the growth of the medical image analysis software market. This report provides a detailed analysis of key industry players, including their business overview, product portfolios, technology capabilities, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments in the medical image analysis software market. This report covers a competitive analysis of established and emerging players in the medical image analysis software ecosystem.
Reasons to buy this report
The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the medical image analysis software market and the subsegments. This report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• The report provides insights on the following pointers: Analysis of key drivers (rising imaging volumes amid growing radiologist workforce shortages, increasing FDA and regulatory clearances for AI-enabled imaging software, growing integration of AI capabilities into imaging hardware systems, rising prevalence of chronic diseases requiring imaging-based diagnosis, increasing venture capital and strategic investment in AI radiology platforms), restraints (high cost of software validation, integration, and deployment, data privacy and cross-border health data regulations), opportunities (expansion of cloud-native and AI-as-a-service imaging platforms, untapped growth potential in emerging markets across Asia Pacific, Latin America, and Middle East & Africa, emerging applications of foundation models and multimodal AI in diagnostic imaging), and challenges (limited interoperability with legacy PACS/RIS and vendor-specific systems, algorithm generalizability and bias across diverse patient populations) influencing the growth of the medical image analysis software market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the medical image analysis software market.
• Market Development: Comprehensive information about lucrative markets; the report analyses the medical image analysis software market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical image analysis software market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Siemens Healthineers AG (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), FUJIFILM Holdings Corporation (Japan), and Aidoc Medical Ltd. (Israel), among others, in the medical image analysis software market.
授權報價
| Single User Licence | $4,950 USD |
| Multi User Licence | $6,650 USD |
| Corporate User Licence | $8,150 USD |
| Global User Licence | $10,000 USD |
目錄 Table of Contents
1 INTRODUCTION 42
1.1 STUDY OBJECTIVES 42
1.2 MARKET DEFINITION 42
1.3 MARKET SCOPE 43
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 43
1.3.2 INCLUSIONS AND EXCLUSIONS 44
1.3.3 YEARS CONSIDERED 45
1.4 CURRENCY 46
1.5 STAKEHOLDERS 46
1.6 SUMMARY OF CHANGES 46
2 EXECUTIVE SUMMARY 48
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 48
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 50
2.3 DISRUPTIVE TRENDS SHAPING THE MARKET 51
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 52
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 53
3 PREMIUM INSIGHTS 54
3.1 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET OVERVIEW 54
3.2 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE & COUNTRY 55
3.3 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: GEOGRAPHIC SNAPSHOT 55
4 MARKET OVERVIEW 56
4.1 INTRODUCTION 56
4.2 MARKET DYNAMICS 57
4.2.1 DRIVERS 57
4.2.1.1 Rising imaging volumes amid growing radiologist workforce shortages 57
4.2.1.2 Increasing FDA and regulatory clearances for AI-enabled imaging software 58
4.2.1.3 Growing demand for early and accurate disease detection 58
4.2.1.4 Increasing adoption of quantitative and workflow-automation solutions 59
4.2.2 RESTRAINTS 59
4.2.2.1 High cost of software validation, integration, and deployment 59
4.2.2.2 Data privacy and cross-border health data regulations 60
4.2.3 OPPORTUNITIES 60
4.2.3.1 Expansion of cloud-native and AI-as-a-service imaging platforms 60
4.2.3.2 Emerging applications of foundation models and multimodal AI in diagnostic imaging 61
4.2.3.3 Expansion into new imaging modalities and clinical specialties 61
4.2.3.4 Integration of image analysis with clinical decision-support and longitudinal care platforms 61
4.2.4 CHALLENGES 62
4.2.4.1 Limited interoperability with legacy PACS/RIS and vendor-specific systems 62
4.2.4.2 Algorithm generalizability and bias across diverse patient populations 62
4.3 UNMET NEEDS AND WHITE SPACES 63
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 64
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 65
5 INDUSTRY TRENDS 67
5.1 PORTER’S FIVE FORCES ANALYSIS 67
5.1.1 BARGAINING POWER OF SUPPLIERS 68
5.1.2 BARGAINING POWER OF BUYERS 68
5.1.3 THREAT OF SUBSTITUTES 68
5.1.4 THREAT OF NEW ENTRANTS 69
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 69
5.2 MACROECONOMIC INDICATORS 69
5.2.1 INTRODUCTION 69
5.2.2 GDP TRENDS AND FORECAST 70
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 71
5.3 VALUE CHAIN ANALYSIS 72
5.3.1 RESEARCH, IMAGING DATA GENERATION, AND CLINICAL INPUTS 73
5.3.2 DATA ENGINEERING & AI INFRASTRUCTURE 73
5.3.3 AI MODEL & PLATFORM DEVELOPMENT 74
5.3.4 WORKFLOW INTEGRATION & INTEROPERABILITY 74
5.3.5 SOFTWARE DEPLOYMENT & CLINICAL SERVICES 74
5.3.6 CLINICAL VALIDATION, MONITORING, AND CONTINUOUS OPTIMIZATION 74
5.4 ECOSYSTEM ANALYSIS 75
5.5 PRICING ANALYSIS 76
5.5.1 MEDICAL IMAGE ANALYSIS SOFTWARE PLATFORMS, BY KEY PLAYERS (2025) 77
5.5.2 INDICATIVE PRICE FOR MEDICAL IMAGE ANALYSIS SOFTWARE, BY REGION (2025) 78
5.6 KEY CONFERENCES AND EVENTS, 2026–2027 80
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 80
5.8 INVESTMENT AND FUNDING SCENARIO 81
5.9 CASE STUDY ANALYSIS 82
5.10 IMPACT OF 2025 US TARIFF – MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 84
5.10.1 INTRODUCTION 84
5.10.2 KEY TARIFF RATES 85
5.10.3 PRICE IMPACT ANALYSIS 85
5.10.4 IMPACT ON COUNTRY/REGION 86
5.10.4.1 US 86
5.10.4.2 Europe 86
5.10.4.3 Asia Pacific 87
5.10.5 IMPACT ON END USERS 87
5.10.5.1 Hospitals and health systems 87
5.10.5.2 Diagnostic imaging centers 87
5.10.5.3 Specialty clinics and ambulatory care providers 87
5.10.5.4 Pharmaceutical and biotechnology companies 88
5.10.5.5 Academic and research institutions 88
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 89
6.1 KEY EMERGING TECHNOLOGIES 89
6.1.1 AI-POWERED DEEP LEARNING AND FOUNDATION MODELS 89
6.1.2 CLOUD-NATIVE MEDICAL IMAGING AND AI-AS-A-SERVICE 90
6.1.3 ADVANCED 3D VISUALIZATION, SEGMENTATION, AND
QUANTITATIVE IMAGING 90
6.2 COMPLEMENTARY TECHNOLOGIES 91
6.2.1 CLOUD COMPUTING AND EDGE COMPUTING 91
6.2.2 INTEROPERABILITY, PACS/VNA, AND CLINICAL DATA INTEGRATION 91
6.3 TECHNOLOGY/PRODUCT ROADMAP 92
6.4 PATENT ANALYSIS 93
6.4.1 PATENT PUBLICATION TRENDS FOR MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 94
6.4.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 95
6.5 FUTURE APPLICATIONS 99
6.5.1 EARLY DISEASE DETECTION AND SCREENING 99
6.5.2 PERSONALIZED TREATMENT PLANNING AND THERAPY GUIDANCE 99
6.5.3 LONGITUDINAL DISEASE MONITORING AND TREATMENT RESPONSE 99
6.6 IMPACT OF AI/GEN AI ON MEDICAL IMAGE ANALYSIS SOFTWARE SOLUTIONS 100
6.6.1 INTRODUCTION 100
6.6.2 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION 102
6.6.2.1 AI-powered chest X-ray analysis for tuberculosis screening 102
6.6.3 IMPACT OF AI/GEN AI ON INTERCONNECTED & ADJACENT ECOSYSTEMS 103
6.6.3.1 PACS/VNA & enterprise imaging market 103
6.6.3.2 AI in medical imaging market 104
6.6.3.3 EHR/Clinical decision support market 104
6.6.4 USER READINESS & IMPACT ASSESSMENT 104
6.6.4.1 User readiness 104
6.6.4.1.1 User A: Healthcare providers 104
6.6.4.1.2 User B: Diagnostic imaging centers 104
6.6.4.2 Impact assessment 105
6.6.4.2.1 User A: Healthcare providers 105
6.6.4.2.2 User B: Diagnostic imaging centers 105
7 REGULATORY LANDSCAPE 106
7.1 REGIONAL REGULATIONS AND COMPLIANCE 106
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
7.1.2 REGULATORY FRAMEWORK 113
7.1.2.1 North America 113
7.1.2.2 Europe 114
7.1.2.3 ASIA PACIFIC 115
7.1.2.4 LATIN AMERICA 116
7.1.2.5 MIDDLE EAST & AFRICA 117
7.1.3 INDUSTRY STANDARDS 118
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 119
8.1 INTRODUCTION 119
8.2 DECISION-MAKING PROCESS 119
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 120
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 120
8.3.2 BUYING CRITERIA 121
8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 122
8.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 122
8.5.1 UNMET NEEDS 123
8.5.2 END USER EXPECTATIONS 123
8.6 MARKET PROFITABILITY 124
9 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER 126
9.1 INTRODUCTION 127
9.2 HOSPITALS 127
9.2.1 INCREASING ADOPTION OF ADVANCED MEDICAL IMAGING AND AI IN HOSPITALS 127
9.3 DIAGNOSTIC IMAGING CENTERS 128
9.3.1 RISING DEMAND FOR EFFICIENT AND HIGH-VOLUME DIAGNOSTIC IMAGING TO BOOST MARKET 128
9.4 ACADEMIC & RESEARCH INSTITUTIONS 129
9.4.1 INCREASING USE OF MEDICAL IMAGE ANALYSIS SOFTWARE IN RESEARCH TO BOOST SEGMENT 129
9.5 OTHER END USERS 130
9.5.1 EXPANDING USE OF MEDICAL IMAGE ANALYSIS BEYOND CONVENTIONAL HEALTHCARE SETTING TO BOOST SEGMENT 130
10 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION 132
10.1 INTRODUCTION 133
10.2 RECONSTRUCTION & VISUALIZATION 133
10.2.1 INCREASING DEMAND FOR HIGH-QUALITY IMAGE RECONSTRUCTION AND 3D VISUALIZATION TO BOOST SEGMENT 133
10.3 DETECTION & LOCALIZATION 134
10.3.1 RISING DEMAND FOR AUTOMATED DETECTION AND LOCALIZATION OF ABNORMALITIES 134
10.4 SEGMENTATION & ANALYSIS 135
10.4.1 INCREASING ADOPTION OF AUTOMATED SEGMENTATION AND QUANTITATIVE IMAGE ANALYSIS 135
10.5 REGISTRATION & COMPARISON 136
10.5.1 GROWING NEED FOR ACCURATE ALIGNMENT AND COMPARISON OF MULTIMODAL MEDICAL IMAGES TO BOOST GROWTH 136
10.6 REPORTING & COMMUNICATION 137
10.6.1 GROWING ADOPTION OF AI-POWERED RADIOLOGY REPORTING AND WORKFLOW AUTOMATION TO DRIVE SEGMENT 137
10.7 CLINICAL DECISION SUPPORT 138
10.7.1 INCREASING ADOPTION OF AI-ASSISTED CLINICAL DECISION SUPPORT 138
11 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE 140
11.1 INTRODUCTION 141
11.2 3D IMAGING 141
11.2.1 GROWING ADOPTION OF 3D IMAGING FOR DETAILED ANATOMICAL VISUALIZATION TO BOOST SEGMENT 141
11.3 4D IMAGING 142
11.3.1 GROWING DEMAND FOR DYNAMIC AND FUNCTIONAL MEDICAL IMAGING TO DRIVE SEGMENT 142
11.4 2D IMAGING 143
11.4.1 CONTINUED DEMAND FOR 2D IMAGING IN ROUTINE DIAGNOSTIC APPLICATIONS – KEY DRIVER 143
12 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY 144
12.1 INTRODUCTION 145
12.2 RADIOGRAPHY (X-RAY) 145
12.2.1 INCREASING ADOPTION OF AI-ENABLED X-RAY ANALYSIS AND WORKFLOW AUTOMATION TO DRIVE SEGMENT 145
12.3 COMPUTED TOMOGRAPHY (CT) 146
12.3.1 SEGMENT DRIVEN BY AI-ENABLED CT IMAGE ANALYSIS FOR RECONSTRUCTION AND DETECTION 146
12.3.2 HIGH-END SLICE CT 147
12.3.2.1 Growing demand for high-resolution and advanced CT imaging – key driver 147
12.3.3 MID-END SLICE CT 148
12.3.3.1 Demand for versatile CT systems with automated analysis to boost growth 148
12.3.4 LOW-END SLICE CT 149
12.3.4.1 Expanding access to cost-efficient CT imaging to propel growth 149
12.4 MAGNETIC RESONANCE IMAGING (MRI) 150
12.4.1 INCREASING ADOPTION OF AI-POWERED MRI RECONSTRUCTION AND WORKFLOW AUTOMATION TO DRIVE MARKET 150
12.4.2 CLOSED MRI SYSTEMS 151
12.4.2.1 Increasing demand for high-resolution and AI-optimized MRI to drive segment 151
12.4.3 OPEN MRI SYSTEMS 152
12.4.3.1 Expanding access to patient-friendly and specialized MRI to drive segment 152
12.5 ULTRASOUND IMAGING 153
12.5.1 INCREASING ADOPTION OF AI-POWERED ULTRASOUND IMAGING
AND WORKFLOW AUTOMATION TO DRIVE MARKET 153
12.5.2 2D ULTRASOUND SYSTEMS 154
12.5.2.1 Expanding use of AI-assisted analysis in routine 2D ultrasound to drive segment 154
12.5.3 3D & 4D ULTRASOUND SYSTEMS 155
12.5.3.1 Increasing demand for volumetric and dynamic ultrasound analysis to boost segment 155
12.5.4 DOPPLER IMAGING 156
12.5.4.1 Growing demand for automated blood-flow assessment 156
12.6 NUCLEAR IMAGING 157
12.6.1 GROWING ADOPTION OF QUANTITATIVE ANALYSIS IN NUCLEAR IMAGING TO BOOST SEGMENT 157
12.6.2 POSITRON EMISSION TOMOGRAPHY (PET) 158
12.6.2.1 Increasing use of quantitative PET for molecular and functional imaging to drive segment 158
12.6.3 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) 159
12.6.3.1 Growing demand for quantitative SPECT in theranostics and cardiovascular imaging 159
12.7 MAMMOGRAPHY 160
12.7.1 INCREASING ADOPTION OF AI-POWERED MAMMOGRAPHY FOR BREAST CANCER DETECTION TO BOOS SEGMENT 160
12.8 COMBINED/HYBRID MODALITIES 161
12.8.1 GROWING ADOPTION OF HYBRID IMAGING FOR INTEGRATED ANATOMICAL AND FUNCTIONAL ANALYSIS TO BOOST SEGMENT 161
12.8.2 PET/CT 162
12.8.2.1 Increasing demand for quantitative PET/CT in oncology 162
12.8.3 SPECT/CT 163
12.8.3.1 Increasing use of SPECT/CT for quantitative assessment and dosimetry 163
12.8.4 PET/MR 164
12.8.4.1 Growing demand for high-resolution multimodal brain and
oncology imaging to propel demand 164
12.9 OTHERS 165
13 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY 167
13.1 INTRODUCTION 168
13.2 AI-ENABLED TECHNOLOGY 168
13.2.1 INCREASING ADOPTION OF AI FOR AUTOMATED AND QUANTITATIVE IMAGE ANALYSIS 168
13.2.2 MACHINE LEARNING 170
13.2.2.1 Increasing use of machine learning for automated medical image analysis to drive segment 170
13.2.3 DEEP LEARNING 171
13.2.3.1 Growing use of deep learning for high-precision medical image reconstruction and analysis to boost segment 171
13.2.4 COMPUTER VISION 172
13.2.4.1 Increasing adoption of computer vision for automated detection and interpretation of medical images to boost segment 172
13.2.5 NATURAL LANGUAGE PROCESSING (NLP) 173
13.2.5.1 Increasing use of NLP for automated radiology reporting and clinical information extraction 173
13.3 CONVENTIONAL TECHNOLOGY 174
13.3.1 CONTINUED DEMAND FOR RELIABLE AND ESTABLISHED IMAGE PROCESSING 174
14 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA 175
14.1 INTRODUCTION 176
14.2 CARDIOLOGY 176
14.2.1 INCREASING ADOPTION OF AI-POWERED CARDIOVASCULAR IMAGE ANALYSIS TO DRIVE MARKET 176
14.3 ONCOLOGY 177
14.3.1 INCREASING USE OF MEDICAL IMAGING AND AI FOR CANCER DETECTION AND TREATMENT MONITORING TO BOOST SEGMENT 177
14.4 NEUROLOGY 178
14.4.1 RISING DEMAND FOR AI-ASSISTED NEUROLOGICAL IMAGING AND EARLY DISEASE DETECTION 178
14.5 ORTHOPEDICS 179
14.5.1 GROWING ADOPTION OF AI-ENABLED IMAGING FOR ORTHOPEDIC DIAGNOSIS AND SURGICAL PLANNING 179
14.6 DENTAL 180
14.6.1 INCREASING ADOPTION OF AI-ENABLED DENTAL IMAGING AND DIAGNOSTIC ANALYSIS TO BOOST SEGMENT 180
14.7 OBSTETRICS & GYNECOLOGY 181
14.7.1 INCREASING ADOPTION OF AI-ENABLED OBSTETRIC AND GYNECOLOGICAL IMAGING 181
14.8 MAMMOGRAPHY/BREAST IMAGING 182
14.8.1 GROWING ADOPTION OF AI FOR BREAST CANCER DETECTION AND MAMMOGRAPHY WORKFLOW OPTIMIZATION 182
14.9 OTHER THERAPEUTIC AREAS 183
14.9.1 EXPANDING APPLICATIONS OF MEDICAL IMAGE ANALYSIS ACROSS EMERGING THERAPEUTIC AREAS 183
15 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE 185
15.1 INTRODUCTION 186
15.2 INTEGRATED SOFTWARE 186
15.2.1 GROWING INTEGRATION OF AI-POWERED IMAGE ANALYSIS INTO CLINICAL WORKFLOWS TO BOOST SEGMENT 186
15.3 STANDALONE SOFTWARE 187
15.3.1 INCREASING ADOPTION OF AI-ENABLED STANDALONE IMAGE ANALYSIS SOLUTIONS TO DRIVE SEGMENT 187
16 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY REGION 189
16.1 INTRODUCTION 190
16.2 NORTH AMERICA 190
16.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 191
16.2.2 US 197
16.2.2.1 Growing demand for faster diagnostics to boost demand 197
16.2.3 CANADA 203
16.2.3.1 Increasing investments in healthcare data infrastructure and medical imaging AI to drive market 203
16.3 EUROPE 209
16.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 210
16.3.2 GERMANY 216
16.3.2.1 Growing adoption of AI-powered medical imaging and radiology solutions to drive market 216
16.3.3 FRANCE 222
16.3.3.1 Increasing adoption of AI-based medical imaging solutions to drive market 222
16.3.4 UK 228
16.3.4.1 Increasing government support for AI-enabled medical imaging to boost market 228
16.3.5 ITALY 234
16.3.5.1 Growing adoption of AI in medical imaging and diagnostic workflows to boost market 234
16.3.6 SPAIN 240
16.3.6.1 Expanding adoption of AI-powered medical imaging solutions to boost market 240
16.3.7 REST OF EUROPE 245
16.4 ASIA PACIFIC 252
16.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 253
16.4.2 CHINA 260
16.4.2.1 Expanding deployment of AI-powered medical imaging solutions to boost market 260
16.4.3 JAPAN 266
16.4.3.1 Growing adoption of AI in medical imaging and radiology to boost market 266
16.4.4 INDIA 272
16.4.4.1 Increasing investment in AI-powered medical imaging and diagnostic infrastructure to drive market 272
16.4.5 AUSTRALIA 278
16.4.5.1 Increasing investment in AI-enabled medical imaging and diagnostic infrastructure 278
16.4.6 SOUTH KOREA 283
16.4.6.1 Strong government and industry investment in AI-enabled
medical imaging 283
16.4.7 REST OF ASIA PACIFIC 289
16.5 LATIN AMERICA 295
16.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 296
16.5.2 BRAZIL 302
16.5.2.1 Increasing investment in AI infrastructure and medical imaging to drive market 302
16.5.3 MEXICO 308
16.5.3.1 Increasing deployment of AI-enabled medical imaging infrastructure 308
16.5.4 REST OF LATIN AMERICA 314
16.5.4.1 Growing adoption of AI in medical imaging to boost market 314
16.6 MIDDLE EAST & AFRICA 320
16.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 320
16.6.2 GCC 326
16.6.2.1 Expanding healthcare digitalization and AI adoption to drive market 326
16.6.2.2 Saudi Arabia 332
16.6.2.2.1 Accelerating adoption of AI in medical imaging – key driver 332
16.6.2.3 UAE 339
16.6.2.3.1 Government-led AI initiatives for smart healthcare to boost market 339
16.6.2.4 Rest of GCC 345
16.6.2.4.1 Increasing healthcare digitization to drive market 345
16.6.3 SOUTH AFRICA 351
16.6.3.1 Growing adoption and readiness for AI-enabled medical imaging to boost market 351
16.6.4 REST OF MIDDLE EAST & AFRICA 356
17 COMPETITIVE LANDSCAPE 363
17.1 INTRODUCTION 363
17.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 363
17.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 364
17.3 REVENUE ANALYSIS, 2021–2025 366
17.4 MARKET SHARE ANALYSIS, 2025 367
17.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 370
17.5.1 STARS 370
17.5.2 EMERGING LEADERS 370
17.5.3 PERVASIVE PLAYERS 371
17.5.4 PARTICIPANTS 371
17.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 373
17.5.5.1 Company footprint 373
17.5.5.2 Region footprint 374
17.5.5.3 Type footprint 375
17.5.5.4 Technology footprint 376
17.5.5.5 Image Type footprint 377
17.6 COMPANY EVALUATION MATRIX: STARTUPS /SMES, 2025 378
17.6.1 PROGRESSIVE COMPANIES 378
17.6.2 RESPONSIVE COMPANIES 378
17.6.3 DYNAMIC COMPANIES 378
17.6.4 STARTING BLOCKS 379
17.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 380
17.6.5.1 Detailed list of key startups/SMEs 380
17.6.5.2 Competitive benchmarking of key startups/SMEs 380
17.7 COMPANY VALUATION AND FINANCIAL METRICS 381
17.8 BRAND/SOFTWARE COMPARISON 382
17.9 COMPETITIVE SCENARIO 383
17.9.1 PRODUCT/SERVICE LAUNCHES & UPGRADES 383
17.9.2 DEALS 383
17.9.3 EXPANSIONS 384
18 COMPANY PROFILES 385
18.1 KEY PLAYERS 385
18.1.1 SIEMENS HEALTHINEERS AG 385
18.1.1.1 Products/solutions/services offered 386
18.1.1.2 Recent developments 388
18.1.1.2.1 Product launches & upgrades 388
18.1.1.2.2 Deals 388
18.1.1.2.3 Expansions 389
18.1.1.3 MnM view 389
18.1.1.3.1 Key strengths 389
18.1.1.3.2 Strategic choices 389
18.1.1.3.3 Weaknesses and competitive threats 389
18.1.2 GE HEALTHCARE 390
18.1.2.1 Business overview 390
18.1.2.2 Products/solutions/services offered 391
18.1.2.3 Recent developments 392
18.1.2.3.1 Product launches & upgrades 393
18.1.2.3.2 Deals 394
18.1.2.4 MnM view 395
18.1.2.4.1 Key strengths 395
18.1.2.4.2 Strategic choices 395
18.1.2.4.3 Weaknesses and competitive threats 395
18.1.3 KONINKLIJKE PHILIPS N.V. 396
18.1.3.1 Business overview 396
18.1.3.2 Products/solutions/services offered 397
18.1.3.3 Recent developments 400
18.1.3.3.1 Product launches & upgrades 400
18.1.3.3.2 Deals 401
18.1.3.3.3 Expansions 401
18.1.3.4 MnM view 402
18.1.3.4.1 Key strengths 402
18.1.3.4.2 Strategic choices 402
18.1.3.4.3 Weaknesses and competitive threats 402
18.1.4 CANON MEDICAL SYSTEMS CORPORATION 403
18.1.4.1 Business overview 403
18.1.4.2 Products/solutions/services offered 404
18.1.4.3 Recent developments 406
18.1.4.3.1 Product launches & upgrades 406
18.1.4.3.2 Deals 406
18.1.5 FUJIFILM HOLDINGS CORPORATION 407
18.1.5.1 Business overview 407
18.1.5.2 Products/solutions/services offered 408
18.1.5.3 Recent developments 409
18.1.5.3.1 Product launches & upgrades 409
18.1.5.3.2 Deals 410
18.1.6 AGFA-GEVAERT N.V. 411
18.1.6.1 Business overview 411
18.1.6.2 Products/solutions/services offered 413
18.1.6.3 Recent developments 414
18.1.6.3.1 Product launches & upgrades 414
18.1.6.3.2 Deals 414
18.1.7 CARESTREAM HEALTH 416
18.1.7.1 Business overview 416
18.1.7.2 Products/solutions/services offered 416
18.1.7.3 Recent developments 417
18.1.7.3.1 Product launches & upgrades 417
18.1.7.3.2 Deals 418
18.1.8 HOLOGIC, INC. 419
18.1.8.1 Business overview 419
18.1.8.2 Products/solutions/services offered 419
18.1.8.3 Recent developments 420
18.1.8.3.1 Product launches & upgrades 420
18.1.8.3.2 Deals 421
18.1.9 MERATIVE 422
18.1.9.1 Business overview 422
18.1.9.2 Products/solutions/services offered 422
18.1.9.3 Recent developments 424
18.1.9.3.1 Product launches & upgrades 424
18.1.9.3.2 Deals 424
18.1.9.3.3 Expansions 424
18.1.10 SECTRA AB 425
18.1.10.1 Business overview 425
18.1.10.2 Products/solutions/services offered 426
18.1.10.3 Recent developments 428
18.1.10.3.1 Product launches & upgrades 428
18.1.10.3.2 Deals 428
18.1.11 BRUKER CORPORATION 430
18.1.11.1 Business overview 430
18.1.11.2 Products/solutions/services offered 431
18.1.12 QUIBIM 433
18.1.12.1 Business overview 433
18.1.12.2 Products/solutions/services offered 433
18.1.12.3 Recent developments 434
18.1.12.3.1 Deals 434
18.1.13 MIRADA MEDICAL LTD. 435
18.1.13.1 Business overview 435
18.1.13.2 Products/solutions/services offered 435
18.1.13.3 Recent developments 436
18.1.13.3.1 Products launches & upgrades 436
18.1.13.3.2 Deals 436
18.1.13.4 Other developments 437
18.1.14 MEDIAN TECHNOLOGIES 438
18.1.14.1 Business overview 438
18.1.14.2 Products/solutions/services offered 439
18.1.14.3 Recent developments 440
18.1.14.3.1 Products launches & upgrades 440
18.1.14.3.2 Deals 441
18.1.15 ELUCID 442
18.1.15.1 Business overview 442
18.1.15.2 Products/solutions/services offered 442
18.1.15.3 Recent developments 443
18.1.15.3.1 Products launches & upgrades 443
18.1.15.3.2 Other developments 443
18.1.16 RAPIDAI, INC. 444
18.1.16.1 Business overview 444
18.1.16.2 Products/solutions/services offered 445
18.1.16.3 Recent developments 446
18.1.16.3.1 Product launches & upgrades 446
18.1.16.3.2 Deals 447
18.1.17 MICROSOFT CORPORATION 448
18.1.17.1 Business overview 448
18.1.17.2 Products/solutions/services offered 449
18.1.17.3 Recent developments 450
18.1.17.3.1 Product launches & upgrades 450
18.1.17.3.2 Deals 451
18.1.18 TEMPUS AI, INC. 453
18.1.18.1 Business overview 453
18.1.18.2 Products/solutions/services offered 454
18.1.18.3 Recent developments 455
18.1.18.3.1 Product launches & upgrades 455
18.1.18.3.2 Deals 456
18.1.19 NANO-X IMAGING LTD 457
18.1.19.1 Business overview 457
18.1.19.2 Products/solutions/services offered 458
18.1.19.3 Recent developments 459
18.1.19.3.1 Product launches & upgrades 459
18.1.19.3.2 Deals 460
18.1.20 CONTEXTVISION AB 461
18.1.20.1 Business overview 461
18.1.20.2 Products/solutions/services offered 462
18.1.20.3 Recent developments 463
18.1.20.3.1 Product launches & upgrades 463
18.1.20.3.2 Deals 463
18.2 OTHER PLAYERS 465
18.2.1 VIZ.AI, INC. 465
18.2.2 AIDOC MEDICAL LTD. 466
18.2.3 AVICENNA.AI 466
18.2.4 CLEERLY, INC. 467
18.2.5 OVERJET, INC. 467
19 RESEARCH METHODOLOGY 468
19.1 RESEARCH APPROACH 468
19.1.1 SECONDARY RESEARCH 468
19.1.1.1 Key data from secondary sources 469
19.1.2 PRIMARY RESEARCH 470
19.1.2.1 Key data from primary sources 471
19.1.2.2 Insights from primary experts 472
19.2 RESEARCH METHODOLOGY DESIGN 473
19.3 MARKET SIZE ESTIMATION 474
19.4 MARKET BREAKDOWN DATA TRIANGULATION 479
19.5 MARKET SHARE ESTIMATION 480
19.6 STUDY ASSUMPTIONS 480
19.7 LIMITATIONS 481
19.7.1 SCOPE-RELATED LIMITATIONS 481
19.7.2 METHODOLOGY-RELATED LIMITATIONS 481
19.8 RISK ASSESSMENT 481
20 APPENDIX 482
20.1 DISCUSSION GUIDE 482
20.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 488
20.3 CUSTOMIZATION OPTIONS 490
20.4 RELATED REPORTS 490
20.5 AUTHOR DETAILS 491
圖表清單 List of Tables & Figures
TABLE 1 USD EXCHANGE RATES 46
TABLE 2 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: PORTER’S FIVE FORCES 67
TABLE 3 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: ROLE IN ECOSYSTEM 76
TABLE 4 INDICATIVE PRICE FOR IMAGE ANALYSIS SOFTWARE PLATFORMS,
BY KEY PLAYERS, 2025 78
TABLE 5 INDICATIVE PRICE FOR MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY REGION (2025) 79
TABLE 6 CASE 1: MERCY'S DEPLOYMENT OF AIDOC AIOS TO ACCELERATE MEDICAL IMAGE ANALYSIS AND CLINICAL TRIAGE 82
TABLE 7 CASE 2: ADVOCATE HEALTH'S EXPANSION OF AIDOC AI FOR ENTERPRISE MEDICAL IMAGING 83
TABLE 8 CASE 3: LUNIT'S AI-ASSISTED MAMMOGRAPHY SCREENING DEPLOYMENT AND CLINICAL VALIDATION 83
TABLE 9 US ADJUSTED RECIPROCAL TARIFF RATES 85
TABLE 10 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET (JANUARY 2015 TO AUGUST 2026) 95
TABLE 11 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: KEY PATENTS/PATENT APPLICATIONS 97
TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 107
TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 108
TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 109
TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110
TABLE 16 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
TABLE 17 REGULATORY SCENARIO IN NORTH AMERICA 113
TABLE 18 REGULATORY SCENARIO IN EUROPE 114
TABLE 19 REGULATORY SCENARIO IN ASIA PACIFIC 115
TABLE 20 REGULATORY SCENARIO IN LATIN AMERICA 116
TABLE 21 REGULATORY SCENARIO IN MIDDLE EAST & AFRICA 117
TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF
TOP THREE END USERS (%) 121
TABLE 23 KEY BUYING CRITERIA FOR TOP THREE END USERS 122
TABLE 24 UNMET NEEDS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 123
TABLE 25 END USER EXPECTATIONS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 124
TABLE 26 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER,
2024–2031 (USD MILLION) 127
TABLE 27 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR HOSPITALS,
BY REGION, 2024–2031 (USD MILLION) 128
TABLE 28 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2024–2031 (USD MILLION) 129
TABLE 29 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2024–2031 (USD MILLION) 130
TABLE 30 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHER END USERS,
BY REGION, 2024–2031 (USD MILLION) 131
TABLE 31 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 133
TABLE 32 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR RECONSTRUCTION & VISUALIZATION, BY REGION, 2024–2031 (USD MILLION) 134
TABLE 33 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DETECTION & LOCALIZATION, BY REGION, 2024–2031 (USD MILLION) 135
TABLE 34 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR SEGMENTATION & ANALYSIS, BY REGION, 2024–2031 (USD MILLION) 136
TABLE 35 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR REGISTRATION & COMPARISON, BY REGION, 2024–2031 (USD MILLION) 137
TABLE 36 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR REPORTING & COMMUNICATION, BY REGION, 2024–2031 (USD MILLION) 138
TABLE 37 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR CLINICAL DECISION SUPPORT, BY REGION, 2024–2031 (USD MILLION) 139
TABLE 38 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE,
2024–2031 (USD MILLION) 141
TABLE 39 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR 3D IMAGING, BY REGION, 2024–2031 (USD MILLION) 142
TABLE 40 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR 4D IMAGING, BY REGION, 2024–2031 (USD MILLION) 142
TABLE 41 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR 2D IMAGING, BY REGION, 2024–2031 (USD MILLION) 143
TABLE 42 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY,
2024–2031 (USD MILLION) 145
TABLE 43 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR RADIOGRAPHY (X-RAY), BY REGION, 2024–2031 (USD MILLION) 146
TABLE 44 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 147
TABLE 45 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY REGION, 2024–2031 (USD MILLION) 147
TABLE 46 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR HIGH-END SLICE CT,
BY REGION, 2024–2031 (USD MILLION) 148
TABLE 47 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MID-END SLICE CT,
BY REGION, 2024–2031 (USD MILLION) 149
TABLE 48 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR LOW-END SLICE CT,
BY REGION, 2024–2031 (USD MILLION) 149
TABLE 49 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 150
TABLE 50 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY REGION, 2024–2031 (USD MILLION) 151
TABLE 51 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR CLOSED MRI SYSTEMS,
BY REGION, 2024–2031 (USD MILLION) 152
TABLE 52 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OPEN MRI SYSTEMS,
BY REGION, 2024–2031 (USD MILLION) 153
TABLE 53 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING,
BY TYPE, 2024–2031 (USD MILLION) 154
TABLE 54 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING,
BY REGION, 2024–2031 (USD MILLION) 154
TABLE 55 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR 2D ULTRASOUND SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 155
TABLE 56 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR 3D & 4D ULTRASOUND SYSTEMS, BY REGION, 2024–2031 (USD MILLION) 156
TABLE 57 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DOPPLER IMAGING,
BY REGION, 2024–2031 (USD MILLION) 157
TABLE 58 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING,
BY TYPE, 2024–2031 (USD MILLION) 158
TABLE 59 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING,
BY REGION, 2024–2031 (USD MILLION) 158
TABLE 60 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR POSITRON EMISSION TOMOGRAPHY (PET), BY REGION, 2024–2031 (USD MILLION) 159
TABLE 61 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT), BY REGION, 2024–2031 (USD MILLION) 160
TABLE 62 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAMMOGRAPHY, BY REGION, 2024–2031 (USD MILLION) 161
TABLE 63 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 162
TABLE 64 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY REGION, 2024–2031 (USD MILLION) 162
TABLE 65 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR PET/CT, BY REGION,
2024–2031 (USD MILLION) 163
TABLE 66 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR SPECT/CT, BY REGION, 2024–2031 (USD MILLION) 164
TABLE 67 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR PET/MR, BY REGION,
2024–2031 (USD MILLION) 165
TABLE 68 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY REGION,
2024–2031 (USD MILLION) 166
TABLE 69 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 168
TABLE 70 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 169
TABLE 71 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY REGION, 2024–2031 (USD MILLION) 169
TABLE 72 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MACHINE LEARNING,
BY REGION, 2024–2031 (USD MILLION) 170
TABLE 73 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DEEP LEARNING,
BY REGION, 2024–2031 (USD MILLION) 171
TABLE 74 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTER VISION,
BY REGION, 2024–2031 (USD MILLION) 172
TABLE 75 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NATURAL LANGUAGE PROCESSING (NLP), BY REGION, 2024–2031 (USD MILLION) 173
TABLE 76 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR CONVENTIONAL TECHNOLOGY, BY REGION, 2024–2031 (USD MILLION) 174
TABLE 77 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA,
2024–2031 (USD MILLION) 176
TABLE 78 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR CARDIOLOGY, BY REGION, 2024–2031 (USD MILLION) 177
TABLE 79 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ONCOLOGY, BY REGION, 2024–2031 (USD MILLION) 178
TABLE 80 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NEUROLOGY, BY REGION, 2024–2031 (USD MILLION) 179
TABLE 81 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ORTHOPEDICS, BY REGION, 2024–2031 (USD MILLION) 180
TABLE 82 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DENTAL, BY REGION,
2024–2031 (USD MILLION) 181
TABLE 83 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OBSTETRICS & GYNECOLOGY, BY REGION, 2024–2031 (USD MILLION) 182
TABLE 84 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAMMOGRAPHY/BREAST IMAGING, BY REGION, 2024–2031 (USD MILLION) 183
TABLE 85 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2024–2031 (USD MILLION) 184
TABLE 86 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 186
TABLE 87 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR INTEGRATED SOFTWARE,
BY REGION, 2024–2031 (USD MILLION) 187
TABLE 88 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR STANDALONE SOFTWARE,
BY REGION, 2024–2031 (USD MILLION) 188
TABLE 89 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY REGION,
2024–2031 (USD MILLION) 190
TABLE 90 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 192
TABLE 91 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY TYPE, 2024–2031 (USD MILLION) 192
TABLE 92 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY TECHNOLOGY, 2024–2031 (USD MILLION) 192
TABLE 93 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 193
TABLE 94 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 193
TABLE 95 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION) 193
TABLE 96 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION) 194
TABLE 97 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 194
TABLE 98 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 195
TABLE 99 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 195
TABLE 100 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 195
TABLE 101 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 196
TABLE 102 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 196
TABLE 103 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION) 197
TABLE 104 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 198
TABLE 105 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 198
TABLE 106 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 198
TABLE 107 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 199
TABLE 108 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE,
2024–2031 (USD MILLION) 199
TABLE 109 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY,
2024–2031 (USD MILLION) 200
TABLE 110 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 200
TABLE 111 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 201
TABLE 112 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 201
TABLE 113 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING,
BY TYPE, 2024–2031 (USD MILLION) 201
TABLE 114 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 202
TABLE 115 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 202
TABLE 116 US: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER,
2024–2031 (USD MILLION) 203
TABLE 117 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 204
TABLE 118 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 204
TABLE 119 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 204
TABLE 120 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 205
TABLE 121 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE,
2024–2031 (USD MILLION) 205
TABLE 122 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY,
2024–2031 (USD MILLION) 206
TABLE 123 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 206
TABLE 124 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 207
TABLE 125 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 207
TABLE 126 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 207
TABLE 127 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 208
TABLE 128 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC
AREA, 2024–2031 (USD MILLION) 208
TABLE 129 CANADA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER,
2024–2031 (USD MILLION) 209
TABLE 130 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 210
TABLE 131 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 211
TABLE 132 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 211
TABLE 133 EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 211
TABLE 134 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 212
TABLE 135 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE,
2024–2031 (USD MILLION) 212
TABLE 136 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY,
2024–2031 (USD MILLION) 213
TABLE 137 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 213
TABLE 138 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 214
TABLE 139 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 214
TABLE 140 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 214
TABLE 141 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/ HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 215
TABLE 142 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 215
TABLE 143 EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER,
2024–2031 (USD MILLION) 216
TABLE 144 GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 217
TABLE 145 GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 217
TABLE 146 GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 217
TABLE 147 GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 218
TABLE 148 GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION) 218
TABLE 149 GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY,
2024–2031 (USD MILLION) 219
TABLE 150 GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 219
TABLE 151 GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 220
TABLE 152 GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 220
TABLE 153 GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 220
TABLE 154 GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 221
TABLE 155 GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 221
TABLE 156 GERMANY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER,
2024–2031 (USD MILLION) 222
TABLE 157 FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 223
TABLE 158 FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 223
TABLE 159 FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 160 FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 224
TABLE 161 FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE,
2024–2031 (USD MILLION) 224
TABLE 162 FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY,
2024–2031 (USD MILLION) 225
TABLE 163 FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 225
TABLE 164 FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 226
TABLE 165 FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 226
TABLE 166 FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 226
TABLE 167 FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 227
TABLE 168 FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 227
TABLE 169 FRANCE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER,
2024–2031 (USD MILLION) 228
TABLE 170 UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 229
TABLE 171 UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 229
TABLE 172 UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 229
TABLE 173 UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 230
TABLE 174 UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE,
2024–2031 (USD MILLION) 230
TABLE 175 UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY,
2024–2031 (USD MILLION) 231
TABLE 176 UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 231
TABLE 177 UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 232
TABLE 178 UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 232
TABLE 179 UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 232
TABLE 180 UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 233
TABLE 181 UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 233
TABLE 182 UK: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER,
2024–2031 (USD MILLION) 234
TABLE 183 ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 235
TABLE 184 ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 235
TABLE 185 ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 235
TABLE 186 ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 236
TABLE 187 ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE,
2024–2031 (USD MILLION) 236
TABLE 188 ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY,
2024–2031 (USD MILLION) 237
TABLE 189 ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 237
TABLE 190 ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 238
TABLE 191 ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 238
TABLE 192 ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING,
BY TYPE, 2024–2031 (USD MILLION) 238
TABLE 193 ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 239
TABLE 194 ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 239
TABLE 195 ITALY: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER,
2024–2031 (USD MILLION) 240
TABLE 196 SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 241
TABLE 197 SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 241
TABLE 198 SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 241
TABLE 199 SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 242
TABLE 200 SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE,
2024–2031 (USD MILLION) 242
TABLE 201 SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY,
2024–2031 (USD MILLION) 243
TABLE 202 SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 243
TABLE 203 SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 243
TABLE 204 SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 244
TABLE 205 SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 244
TABLE 206 SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 244
TABLE 207 SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 245
TABLE 208 SPAIN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER,
2024–2031 (USD MILLION) 245
TABLE 209 REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY TYPE, 2024–2031 (USD MILLION) 246
TABLE 210 REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY TECHNOLOGY, 2024–2031 (USD MILLION) 246
TABLE 211 REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 247
TABLE 212 REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY FUNCTION, 2024–2031 (USD MILLION) 247
TABLE 213 REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION) 248
TABLE 214 REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION) 248
TABLE 215 REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 249
TABLE 216 REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 249
TABLE 217 REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 249
TABLE 218 REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 250
TABLE 219 REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 250
TABLE 220 REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 251
TABLE 221 REST OF EUROPE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION) 251
TABLE 222 ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 254
TABLE 223 ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 254
TABLE 224 ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 255
TABLE 225 ASIA PACIFIC: AI-ENABLED TECHNOLOGY MARKET, BY TYPE,
2024–2031 (USD MILLION) 255
TABLE 226 ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 255
TABLE 227 ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION) 256
TABLE 228 ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION) 256
TABLE 229 ASIA PACIFIC: COMPUTED TOMOGRAPHY (CT) MARKET, BY TYPE,
2024–2031 (USD MILLION) 257
TABLE 230 ASIA PACIFIC: MAGNETIC RESONANCE IMAGING (MRI) MARKET, BY TYPE,
2024–2031 (USD MILLION) 257
TABLE 231 ASIA PACIFIC: ULTRASOUND IMAGING MARKET, BY TYPE,
2024–2031 (USD MILLION) 257
TABLE 232 ASIA PACIFIC: NUCLEAR IMAGING MARKET, BY TYPE, 2024–2031 (USD MILLION) 258
TABLE 233 ASIA PACIFIC: COMBINED/HYBRID MODALITIES MARKET, BY TYPE,
2024–2031 (USD MILLION) 258
TABLE 234 ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 259
TABLE 235 ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION) 259
TABLE 236 CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 260
TABLE 237 CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 261
TABLE 238 CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE FOR AI-ENABLED TECHNOLOGY,
BY TYPE, 2024–2031 (USD MILLION) 261
TABLE 239 CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 262
TABLE 240 CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE,
2024–2031 (USD MILLION) 262
TABLE 241 CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY,
2024–2031 (USD MILLION) 263
TABLE 242 CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 263
TABLE 243 CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 264
TABLE 244 CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 264
TABLE 245 CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 264
TABLE 246 CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 265
TABLE 247 CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 265
TABLE 248 CHINA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER,
2024–2031 (USD MILLION) 266
TABLE 249 JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 266
TABLE 250 JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 267
TABLE 251 JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 267
TABLE 252 JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 267
TABLE 253 JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE,
2024–2031 (USD MILLION) 268
TABLE 254 JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY,
2024–2031 (USD MILLION) 268
TABLE 255 JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 269
TABLE 256 JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) MARKET, BY TYPE, 2024–2031 (USD MILLION) 269
TABLE 257 JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 269
TABLE 258 JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 270
TABLE 259 JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 270
TABLE 260 JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 271
TABLE 261 JAPAN: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER,
2024–2031 (USD MILLION) 271
TABLE 262 INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 273
TABLE 263 INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 273
TABLE 264 INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 273
TABLE 265 INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 274
TABLE 266 INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE,
2024–2031 (USD MILLION) 274
TABLE 267 INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY,
2024–2031 (USD MILLION) 275
TABLE 268 INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE FOR COMPUTED TOMOGRAPHY (CT) MARKET, BY TYPE, 2024–2031 (USD MILLION) 275
TABLE 269 INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 275
TABLE 270 INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 276
TABLE 271 INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING,
BY TYPE, 2024–2031 (USD MILLION) 276
TABLE 272 INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE FOR COMBINED/HYBRID MODALITIES MARKET, BY TYPE, 2024–2031 (USD MILLION) 276
TABLE 273 INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 277
TABLE 274 INDIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER,
2024–2031 (USD MILLION) 277
TABLE 275 AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 278
TABLE 276 AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 279
TABLE 277 AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 279
TABLE 278 AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 279
TABLE 279 AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION) 280
TABLE 280 AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION) 280
TABLE 281 AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 281
TABLE 282 AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 281
TABLE 283 AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 281
TABLE 284 AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE FOR NUCLEAR IMAGING,
BY TYPE, 2024–2031 (USD MILLION) 282
TABLE 285 AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 282
TABLE 286 AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 283
TABLE 287 AUSTRALIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION) 283
TABLE 288 SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 284
TABLE 289 SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 284
TABLE 290 SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 285
TABLE 291 SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 285
TABLE 292 SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION) 286
TABLE 293 SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION) 286
TABLE 294 SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 287
TABLE 295 SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 287
TABLE 296 SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 287
TABLE 297 SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 288
TABLE 298 SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 288
TABLE 299 SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 289
TABLE 300 SOUTH KOREA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION) 289
TABLE 301 REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY TYPE, 2024–2031 (USD MILLION) 290
TABLE 302 REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY TECHNOLOGY, 2024–2031 (USD MILLION) 291
TABLE 303 REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 291
TABLE 304 REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY FUNCTION, 2024–2031 (USD MILLION) 291
TABLE 305 REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION) 292
TABLE 306 REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY MODALITY, 2024–2031 (USD MILLION) 292
TABLE 307 REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 293
TABLE 308 REST OF ASIA PACIFIC: MAGNETIC RESONANCE IMAGING (MRI) MARKET,
BY TYPE, 2024–2031 (USD MILLION) 293
TABLE 309 REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 293
TABLE 310 REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 294
TABLE 311 REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 294
TABLE 312 REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 295
TABLE 313 REST OF ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION) 295
TABLE 314 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 296
TABLE 315 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 297
TABLE 316 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY TECHNOLOGY, 2024–2031 (USD MILLION) 297
TABLE 317 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 297
TABLE 318 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 298
TABLE 319 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION) 298
TABLE 320 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION) 299
TABLE 321 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 299
TABLE 322 LATIN AMERICA: MAGNETIC RESONANCE IMAGING (MRI) MARKET,
BY TYPE, 2024–2031 (USD MILLION) 300
TABLE 323 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 300
TABLE 324 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 300
TABLE 325 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 301
TABLE 326 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 301
TABLE 327 LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION) 302
TABLE 328 BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 303
TABLE 329 BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 303
TABLE 330 BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 303
TABLE 331 BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 304
TABLE 332 BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE,
2024–2031 (USD MILLION) 304
TABLE 333 BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY,
2024–2031 (USD MILLION) 305
TABLE 334 BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 305
TABLE 335 BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 306
TABLE 336 BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 306
TABLE 337 BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 306
TABLE 338 BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 307
TABLE 339 BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 307
TABLE 340 BRAZIL: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER,
2024–2031 (USD MILLION) 308
TABLE 341 MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 309
TABLE 342 MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 309
TABLE 343 MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 309
TABLE 344 MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 310
TABLE 345 MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE,
2024–2031 (USD MILLION) 310
TABLE 346 MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY,
2024–2031 (USD MILLION) 311
TABLE 347 MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT) MARKET, BY TYPE, 2024–2031 (USD MILLION) 311
TABLE 348 MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 311
TABLE 349 MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 312
TABLE 350 MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 312
TABLE 351 MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 312
TABLE 352 MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 313
TABLE 353 MEXICO: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER,
2024–2031 (USD MILLION) 313
TABLE 354 REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY TYPE, 2024–2031 (USD MILLION) 314
TABLE 355 REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY TECHNOLOGY, 2024–2031 (USD MILLION) 315
TABLE 356 REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 315
TABLE 357 REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY FUNCTION, 2024–2031 (USD MILLION) 315
TABLE 358 REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY IMAGE TYPE, 2024–2031 (USD MILLION) 316
TABLE 359 REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY MODALITY, 2024–2031 (USD MILLION) 316
TABLE 360 REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 317
TABLE 361 REST OF LATIN AMERICA: MAGNETIC RESONANCE IMAGING (MRI) MARKET,
BY TYPE, 2024–2031 (USD MILLION) 317
TABLE 362 REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 317
TABLE 363 REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 318
TABLE 364 REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 318
TABLE 365 REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 319
TABLE 366 REST OF LATIN AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY END USER, 2024–2031 (USD MILLION) 319
TABLE 367 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 321
TABLE 368 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY TYPE, 2024–2031 (USD MILLION) 321
TABLE 369 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY TECHNOLOGY, 2024–2031 (USD MILLION) 321
TABLE 370 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 322
TABLE 371 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY FUNCTION, 2024–2031 (USD MILLION) 322
TABLE 372 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY IMAGE TYPE, 2024–2031 (USD MILLION) 322
TABLE 373 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY MODALITY, 2024–2031 (USD MILLION) 323
TABLE 374 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 323
TABLE 375 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 324
TABLE 376 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 324
TABLE 377 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 324
TABLE 378 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 325
TABLE 379 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 325
TABLE 380 MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET,
BY END USER, 2024–2031 (USD MILLION) 326
TABLE 381 GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 327
TABLE 382 GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 327
TABLE 383 GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 328
TABLE 384 GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 328
TABLE 385 GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 328
TABLE 386 GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE,
2024–2031 (USD MILLION) 329
TABLE 387 GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY,
2024–2031 (USD MILLION) 329
TABLE 388 GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 330
TABLE 389 GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 330
TABLE 390 GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 330
TABLE 391 GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING,
BY TYPE, 2024–2031 (USD MILLION) 331
TABLE 392 GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/ HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 331
TABLE 393 GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 332
TABLE 394 GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER,
2024–2031 (USD MILLION) 332
TABLE 395 SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 333
TABLE 396 SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 334
TABLE 397 SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 334
TABLE 398 SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 334
TABLE 399 SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION) 335
TABLE 400 SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION) 335
TABLE 401 SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 336
TABLE 402 SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 336
TABLE 403 SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 336
TABLE 404 SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 337
TABLE 405 SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 337
TABLE 406 SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 338
TABLE 407 SAUDI ARABIA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION) 338
TABLE 408 UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 339
TABLE 409 UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY,
2024–2031 (USD MILLION) 340
TABLE 410 UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 340
TABLE 411 UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 340
TABLE 412 UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE,
2024–2031 (USD MILLION) 341
TABLE 413 UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY,
2024–2031 (USD MILLION) 341
TABLE 414 UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 342
TABLE 415 UAE: MEDICAL IMAGING ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) MARKET, BY TYPE, 2024–2031 (USD MILLION) 342
TABLE 416 UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 342
TABLE 417 UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING,
BY TYPE, 2024–2031 (USD MILLION) 343
TABLE 418 UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 343
TABLE 419 UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 344
TABLE 420 UAE: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER,
2024–2031 (USD MILLION) 344
TABLE 421 REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 346
TABLE 422 REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 346
TABLE 423 REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 346
TABLE 424 REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 347
TABLE 425 REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION) 347
TABLE 426 REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION) 348
TABLE 427 REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 348
TABLE 428 REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 348
TABLE 429 REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 349
TABLE 430 REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 349
TABLE 431 REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 349
TABLE 432 REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 350
TABLE 433 REST OF GCC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION) 350
TABLE 434 SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE,
2024–2031 (USD MILLION) 351
TABLE 435 SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 352
TABLE 436 SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 352
TABLE 437 SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 352
TABLE 438 SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION) 353
TABLE 439 SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION) 353
TABLE 440 SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 354
TABLE 441 SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 354
TABLE 442 SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 354
TABLE 443 SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 355
TABLE 444 SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 355
TABLE 445 SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 356
TABLE 446 SOUTH AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION) 356
TABLE 447 REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 357
TABLE 448 REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION) 357
TABLE 449 REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR AI-ENABLED TECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION) 358
TABLE 450 REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 358
TABLE 451 REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE, 2024–2031 (USD MILLION) 359
TABLE 452 REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2024–2031 (USD MILLION) 359
TABLE 453 REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY (CT), BY TYPE, 2024–2031 (USD MILLION) 360
TABLE 454 REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY TYPE, 2024–2031 (USD MILLION) 360
TABLE 455 REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND IMAGING, BY TYPE, 2024–2031 (USD MILLION) 360
TABLE 456 REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024–2031 (USD MILLION) 361
TABLE 457 REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED/HYBRID MODALITIES, BY TYPE, 2024–2031 (USD MILLION) 361
TABLE 458 REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA, 2024–2031 (USD MILLION) 362
TABLE 459 REST OF MIDDLE EAST & AFRICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2024–2031 (USD MILLION) 362
TABLE 460 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES 364
TABLE 461 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: DEGREE OF COMPETITION, 2025 368
TABLE 462 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: REGION FOOTPRINT 374
TABLE 463 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: TYPE FOOTPRINT 375
TABLE 464 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: TECHNOLOGY FOOTPRINT 376
TABLE 465 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: IMAGE TYPE FOOTPRINT 377
TABLE 466 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES 380
TABLE 467 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 380
TABLE 468 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: PRODUCT/SERVICE LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026 383
TABLE 469 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: DEALS,
JANUARY 2023–AUGUST 2026 383
TABLE 470 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: EXPANSIONS, JANUARY 2023– AUGUST 2026 384
TABLE 471 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW 385
TABLE 472 SIEMENS HEALTHINEERS AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 386
TABLE 473 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026 388
TABLE 474 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2023–AUGUST 2026 388
TABLE 475 SIEMENS HEALTHINEERS: EXPANSIONS, JANUARY 2023–JULY 2026 389
TABLE 476 GE HEALTHCARE: BUSINESS OVERVIEW 390
TABLE 477 GE HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 391
TABLE 478 GE HEALTHCARE: PRODUCT LAUNCHES & UPGRADES,
JANUARY 2023– AUGUST 2026 393
TABLE 479 GE HEALTHCARE: DEALS, JANUARY 2023– AUGUST 2026 394
TABLE 480 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 396
TABLE 481 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 397
TABLE 482 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023– AUGUST 2026 400
TABLE 483 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023–AUGUST 2026 401
TABLE 484 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2023–AUGUST 2026 401
TABLE 485 CANON MEDICAL SYSTEMS CORPORATION: BUSINESS OVERVIEW 403
TABLE 486 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS/SOLUTIONS/
SERVICES OFFERED 404
TABLE 487 CANON MEDICAL SYSTEMS CORPORATION: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023– AUGUST 2026 406
TABLE 488 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2023–AUGUST 2026 406
TABLE 489 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW 407
TABLE 490 FUJIFILM HOLDINGS CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 408
TABLE 491 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026 409
TABLE 492 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2023–AUGUST 2026 410
TABLE 493 AGFA-GEVAERT N.V.: BUSINESS OVERVIEW 411
TABLE 494 AGFA-GEVAERT N.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 413
TABLE 495 AGFA-GEVAERT N.V.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–
AUGUST 2026 414
TABLE 496 AGFA-GEVAERT N.V.: DEALS, JANUARY 2023–AUGUST 2026 414
TABLE 497 CARESTREAM HEALTH: BUSINESS OVERVIEW 416
TABLE 498 CARESTREAM HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 416
TABLE 499 CARESTREAM HEALTH: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023– AUGUST 2026 417
TABLE 500 CARESTREAM HEALTH: DEALS, JANUARY 2023–AUGUST 2026 418
TABLE 501 HOLOGIC, INC.: BUSINESS OVERVIEW 419
TABLE 502 HOLOGIC, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 419
TABLE 503 HOLOGIC, INC.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026 420
TABLE 504 HOLOGIC, INC.: DEALS, JANUARY 2023–AUGUST 2026 421
TABLE 505 MERATIVE: BUSINESS OVERVIEW 422
TABLE 506 MERATIVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 422
TABLE 507 MERATIVE: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026 424
TABLE 508 MERATIVE: DEALS, JANUARY 2023–AUGUST 2026 424
TABLE 509 MERATIVE: EXPANSIONS, JANUARY 2023–AUGUST 2026 424
TABLE 510 SECTRA AB: BUSINESS OVERVIEW 425
TABLE 511 SECTRA AB: PRODUCTS/SOLUTIONS/SERVICES OFFERED 426
TABLE 512 SECTRA AB: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023– AUGUST 2026 428
TABLE 513 SECTRA AB: DEALS, JANUARY 2023–AUGUST 2026 428
TABLE 514 BRUKER CORPORATION: BUSINESS OVERVIEW 430
TABLE 515 BRUKER CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 431
TABLE 516 QUIBIM: BUSINESS OVERVIEW 433
TABLE 517 QUIBIM: PRODUCTS/SOLUTIONS/SERVICES OFFERED 433
TABLE 518 QUIBIM: DEALS, JANUARY 2023–AUGUST 2026 434
TABLE 519 MIRADA MEDICAL LTD.: BUSINESS OVERVIEW 435
TABLE 520 MIRADA MEDICAL LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 435
TABLE 521 MIRADA MEDICAL LTD.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026 436
TABLE 522 MIRADA MEDICAL LTD.: DEALS, JANUARY 2023–AUGUST 2026 436
TABLE 523 MIRADA MEDICAL LTD.: OTHER DEVELOPMENTS, JANUARY 2023–AUGUST 2026 437
TABLE 524 MEDIAN TECHNOLOGIES: BUSINESS OVERVIEW 438
TABLE 525 MEDIAN TECHNOLOGIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 439
TABLE 526 MEDIAN TECHNOLOGIES: PRODUCTS LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026 440
TABLE 527 MEDIAN TECHNOLOGIES: DEALS, JANUARY 2023–AUGUST 2026 441
TABLE 528 ELUCID: BUSINESS OVERVIEW 442
TABLE 529 ELUCID: PRODUCTS/SOLUTIONS/SERVICES OFFERED 442
TABLE 530 ELUCID: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026 443
TABLE 531 ELUCID: OTHER DEVELOPMENTS, JANUARY 2023–AUGUST 2026 443
TABLE 532 RAPIDAI INC.: BUSINESS OVERVIEW 444
TABLE 533 RAPIDAI INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 445
TABLE 534 RAPIDAI INC.: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026 446
TABLE 535 RAPIDAI INC.: DEALS, JANUARY 2023–AUGUST 2026 447
TABLE 536 MICROSOFT CORPORATION: BUSINESS OVERVIEW 448
TABLE 537 MICROSOFT CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 449
TABLE 538 MICROSOFT CORPORATION: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026 450
TABLE 539 MICROSOFT CORPORATION: DEALS, JANUARY 2023–AUGUST 2026 451
TABLE 540 TEMPUS AI, INC.: BUSINESS OVERVIEW 453
TABLE 541 TEMPUS AI, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 454
TABLE 542 TEMPUS AI, INC.: PRODUCT LAUNCHES & UPGRADES,
JANUARY 2023–AUGUST 2026 455
TABLE 543 TEMPUS AI, INC.: DEALS, JANUARY 2023–AUGUST 2026 456
TABLE 544 NANO-X IMAGING LTD: BUSINESS OVERVIEW 457
TABLE 545 NANO-X IMAGING LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED 458
TABLE 546 NANO-X IMAGING LTD: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023–AUGUST 2026 459
TABLE 547 NANO-X IMAGING LTD: DEALS, JANUARY 2023–AUGUST 2026 460
TABLE 548 CONTEXTVISION AB: BUSINESS OVERVIEW 461
TABLE 549 CONTEXTVISION AB: PRODUCTS/SOLUTIONS/SERVICES OFFERED 462
TABLE 550 CONTEXTVISION AB: PRODUCT LAUNCHES & UPGRADES,
JANUARY 2023–AUGUST 2026 463
TABLE 551 CONTEXTVISION AB: DEALS, JANUARY 2023–AUGUST 2026 463
TABLE 552 RISK ASSESSMENT: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 481
FIGURE 1 MARKET SCENARIO 49
FIGURE 2 GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2024–2031 49
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2023–2026 50
FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 51
FIGURE 5 HIGH-GROWTH SEGMENTS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2026–2031 52
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET DURING FORECAST PERIOD 53
FIGURE 7 RISING DEMAND FOR MEDICAL IMAGE ANALYSIS SOFTWARE AND INCREASED ADOPTION TO REDUCE DIAGNOSIS TIMELINES & COSTS TO DRIVE GROWTH 54
FIGURE 8 INTEGRATED SOFTWARE ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2025 55
FIGURE 9 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 55
FIGURE 10 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: PORTER’S FIVE FORCES ANALYSIS 68
FIGURE 11 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: VALUE CHAIN ANALYSIS 73
FIGURE 12 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: ECOSYSTEM ANALYSIS 75
FIGURE 13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81
FIGURE 14 RECENT FUNDING OF PLAYERS IN THE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 82
FIGURE 15 PATENT PUBLICATION TRENDS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2015–2026 95
FIGURE 16 JURISDICTION AND TOP APPLICANT ANALYSIS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET (JANUARY 2015 TO AUGUST 2026) 95
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET (JANUARY 2015 TO AUGUST 2026) 96
FIGURE 18 MARKET POTENTIAL OF AI/GEN AI ON MEDICAL IMAGE ANALYSIS SOFTWARE ACROSS END USERS 101
FIGURE 19 IMPACT OF AI/GEN AI ON INTERCONNECTED & ADJACENT ECOSYSTEMS 103
FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 120
FIGURE 21 KEY BUYING CRITERIA FOR TOP THREE END USERS 121
FIGURE 22 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SNAPSHOT 191
FIGURE 23 ASIA PACIFIC: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET SNAPSHOT 253
FIGURE 24 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: REVENUE ANALYSIS OF TOP FIVE PLAYERS, 2021–2025 366
FIGURE 25 MARKET SHARE ANALYSIS OF COMPANIES OFFERING MEDICAL IMAGE ANALYSIS SOFTWARE SERVICES/SOLUTIONS, 2025 368
FIGURE 26 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 372
FIGURE 27 FOOTPRINT OF COMPANIES IN THE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET 373
FIGURE 28 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 379
FIGURE 29 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF MEDICAL IMAGE ANALYSIS SOFTWARE VENDORS 381
FIGURE 30 FINANCIAL METRICS (EV/EBITDA) 381
FIGURE 31 BRAND/PRODUCT COMPARATIVE ANALYSIS 382
FIGURE 32 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025) 386
FIGURE 33 GE HEALTHCARE: COMPANY SNAPSHOT (2025) 391
FIGURE 34 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025) 397
FIGURE 35 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2025) 404
FIGURE 36 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025) 408
FIGURE 37 AGFA-GEVAERT N.V.: COMPANY SNAPSHOT (2025) 412
FIGURE 38 SECTRA AB: COMPANY SNAPSHOT (2026) 426
FIGURE 39 BRUKER CORPORATION: COMPANY SNAPSHOT (2025) 431
FIGURE 40 MEDIAN TECHNOLOGIES: COMPANY SNAPSHOT (2025) 439
FIGURE 41 MICROSOFT CORPORATION: COMPANY SNAPSHOT (2026) 449
FIGURE 42 TEMPUS AI, INC.: COMPANY SNAPSHOT (2025) 454
FIGURE 43 NANO-X IMAGING LTD: COMPANY SNAPSHOT (2025) 458
FIGURE 44 CONTEXTVISION AB: COMPANY SNAPSHOT (2025) 462
FIGURE 45 RESEARCH DESIGN 468
FIGURE 46 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 472
FIGURE 47 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 473
FIGURE 48 BOTTOM-UP APPROACH 474
FIGURE 49 TOP-DOWN APPROACH 475
FIGURE 50 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 476
FIGURE 51 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: CAGR PROJECTION ANALYSIS 476
FIGURE 52 DATA TRIANGULATION METHODOLOGY 479
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們